Money
The US Census: Redistricting Data; What to Expect and When
"As we prepare to release these 2020 Census data, I wanted to let you know what to expect when you look at the statistics. As it does every decade, the census will reflect the demographic changes that have occurred over the span of 10 years. Our results also will likely show some effects from the current pandemic. For example, some people relocated, and based on the 2020 Census Residence Criteria and Residence Situations, they may have been counted in a different place than they would have lived otherwise. Every way we’ve analyzed the 2020 Census — through our extensive reviews during data processing, by comparing the numbers to population benchmarks, and looking at the operations — the census data are high quality and are fit to use for redistricting. In fact, the quality of the 2020 Census data is quite remarkable amid all the challenges we faced last year." more »
Biden-Harris Administration Marks Anniversary of Americans with Disabilities Act and Announces Resources to Support Individuals with Long COVID, Increased Access to Democracy for Voters with Disabilities
"The Biden-Harris Administration has taken significant steps to achieve a more inclusive, accessible, and equitable country for people with disabilities, including people with disabilities that experience multiple forms of discrimination and bias on the basis of race, gender, sexual orientation and other factors. Through quick policy action, the Administration has ensured disabled Americans are receiving resources and are included in key administrative proposals:" Centered Equity as a Priority on Day One. President Biden’s Inauguration Day Executive Order 13985 on Advancing Racial Equity and Support for Underserved Communities. Increased Access to Democracy for Voters with Disabilities. Advanced Diversity, Equity, Inclusion, and Accessibility Across the Federal Government. more »
Kaiser Health News: Paying Billions for Controversial Alzheimer’s Drug? How About Funding This Instead?
Aduhelm, a new Alzheimer’s drug approved by the Food and Drug Administration last month, could be prescribed to 1 million to 2 million patients a year, even if conservative criteria were used, according to Biogen and Eisai, the companies behind the drug. The total annual price tag would come to $56 billion if the average list price, $56,000, is applied to the lower end of the companies’ estimate. That’s a huge sum by any measure — more than the annual budget for the National Institutes of Health (almost $43 billion this year). Yet there’s considerable uncertainty about Aduhelm’s clinical benefits, fueling controversy over its approval. The FDA has acknowledged it’s not clear whether the medication will actually slow the progression of Alzheimer’s disease or by how much. more »
Federal Reserve Bank of St. Louis: US Economic Activity Contracted Sharply During 2020 As Covid-19 Spread and Government Introduced Policies Aimed At Curbing the Virus
US economic activity contracted sharply during 2020 as COVID-19 spread and government introduced policies aimed at curbing the virus. Understanding the impact of the pandemic on economic activity as well as the effectiveness and economic impact of health and containment policies has been a major challenge faced by policymakers. The fundamental issue is that economic activity, COVID-19's spread, and health and containment policies are interconnected — they simultaneously influence each other. In a recent working paper, we develop a methodology to investigate the causal linkages among COVID-19's spread, health and containment policies, and economic activity.1 In this two-part essay, we present a nontechnical summary of our approach and main findings. In particular, Part I explains our methods and summarizes how COVID-19 has affected economic activity and government policies. Part II describes the effects of government policies on COVID-19's spread and economic activity. more »